BioJapan
BioJapan is Asia’s premier partnering event for the international biotechnology industry...
Login / Register
Search
BioJapan is Asia’s premier partnering event for the international biotechnology industry...
PR euroCHEM / SME / Search for Partners in JapanFounded in 1998 in Ireland, PR euroCHEM is...
What should you know when entering Pharmaceutical market in Japan? Various EU products and...
Various EU products and services began to enjoy benefits from the EU-Japan Economic...
Quasi-drugs are medicines for the purpose of prevention of symptoms and hygiene : they have a weaker effect on the human body than medicines. Some products, such as nutritional drinks, shampoos and hair-growth products, are considered “quasi-drugs”, whereas skincare products that are less effective than “quasi-drugs” are classified as cosmetics.
About the Report: The Japanese market for pharmaceuticals is amongst the largest in the...
About the Report This report titled "The pharmaceuticals industry in Japan: current trends...
Which opportunities does the Biopharmaceutical market in Japan offer to EU companies?Among...
What business opportunities currently exist for European SMEs seeking to invest in...
How can I access the Japanese market as a novel biopharmaceutical product's owner?Japan...
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
